Atropine: Drug Dose, Side Effects and GPAT Exam Notes

Introduction to Atropine

Atropine is the prototype antimuscarinic agent in autonomic pharmacology. It is a naturally occurring tertiary amine alkaloid extracted from Atropa belladonna (deadly nightshade) and Datura stramonium.

In competitive exams like GPAT and NIPER, questions frequently test atropine mechanism of action, dose-dependent effects, and atropine toxicity. Understanding its clinical dosage and adverse reactions helps students solve both clinical case problems and direct recall questions.

Mechanism of Action

Atropine acts as a competitive, non-selective antagonist at all muscarinic acetylcholine receptor subtypes (M1, M2, M3, M4, and M5).

• It prevents acetylcholine (ACh) from binding to muscarinic receptors on target organs.
• It blocks parasympathetic neuroeffector junctions in smooth muscle, cardiac tissue, exocrine glands, and the central nervous system (CNS).
• It can be overcome by increasing the concentration of acetylcholine, such as through acetylcholinesterase inhibitors.
• Atropine does not block nicotinic receptors at therapeutic doses.

Pharmacological Actions

Atropine alters organ systems throughout the human body:

Cardiovascular System

• Heart Rate: Low doses (0.5 mg) cause mild, paradoxical bradycardia. This occurs due to central vagal stimulation and blockade of presynaptic inhibitory M1 receptors on postganglionic vagal nerve endings. Higher doses (1 mg and above) block M2 receptors on the sinoatrial (SA) node, causing tachycardia.
• AV Conduction: It shortens the refractory period of the atrioventricular (AV) node and accelerates conduction.

Ocular System

• Mydriasis: Atropine blocks M3 receptors on the pupillary sphincter muscle, leading to passive pupil dilation.
• Cycloplegia: It paralyzes the ciliary muscle, causing loss of accommodation for near vision.
• Intraocular Pressure: Pupil dilation crowds the iris into the iridocorneal angle, blocking aqueous humor drainage. This sharply elevates intraocular pressure (IOP).

Secretions and Smooth Muscle

• Glandular Secretions: It potently inhibits salivary, sweat, bronchial, and lacrimal secretions.
• Respiratory Tract: It causes bronchodilation and reduces airway mucus secretion.
• Gastrointestinal Tract: It decreases intestinal tone, amplitude, and frequency of peristaltic contractions.
• Urinary Bladder: It relaxes the detrusor muscle and contracts the internal urethral sphincter, promoting urinary retention.

Dose-Dependent Effects of Atropine

Different physiological functions show different sensitivity to muscarinic blockade. GPAT examiners frequently ask which organ responds first to escalating atropine doses.

Atropine Dose	Clinical Effects Observed
0.5 mg	Mild cardiac slowing, mild dry mouth, inhibition of sweating
1.0 mg	Definite dry mouth, thirst, mild tachycardia, mild pupil dilation
2.0 mg	Rapid heart rate, marked palpitation, blurred near vision, dilated pupils
5.0 mg	Difficulty speaking and swallowing, hot dry skin, reduced bowel sounds, restlessness
10.0 mg or more	Rapid weak pulse, ataxia, hallucinations, delirium, coma, respiratory paralysis

Clinical Uses and Standard Drug Doses

Atropine is indicated in emergency, perioperative, and diagnostic medicine.

• Hemodynamically Unstable Bradycardia:
  • Standard dose: 0.5 mg to 1 mg IV push.
  • Repeat every 3 to 5 minutes as needed.
  • Maximum cumulative dose: 3 mg in adults.
• Organophosphate and Carbamate Poisoning:
  • Standard starting dose: 2 mg to 4 mg IV.
  • Repeat every 5 to 10 minutes until full atropinisation occurs (clear chest, heart rate above 80 bpm, dry axillae, dilated pupils).
• Pre-anaesthetic Medication:
  • Standard dose: 0.4 mg to 0.6 mg IM or IV 30 to 60 minutes before surgery to reduce bronchial and salivary secretions.
• Ophthalmic Use (Refraction testing):
  • 1% ophthalmic drop or ointment.
  • Causes prolonged cycloplegia lasting up to 7 to 10 days.

Side Effects and Atropine Toxicity

Adverse effects of atropine are predictable extensions of its antimuscarinic pharmacology.

Common side effects include:

• Dryness of mouth (xerostomia)
• Blurred vision and photophobia
• Constipation and urinary retention
• Flushing and hyperthermia (due to suppressed sweating)
• Palpitations and restlessness

The Anticholinergic Toxidrome

Severe overdose produces the classic anticholinergic toxidrome. Pharmacy students can recall this with the famous medical mnemonic:

• Dry as a bone: Complete suppression of sweat, salivary, and bronchial secretions.
• Red as a beet: Cutaneous vasodilation in the blush area to lose heat (atropine flush).
• Blind as a bat: Extreme mydriasis and cycloplegia.
• Hot as a hare: Dangerous hyperthermia due to loss of sweating.
• Mad as a hatter: CNS excitation, visual hallucinations, confusion, and delirium.
• Full as a flask: Acute urinary retention from detrusor relaxation.

Management of Atropine Poisoning

1. Supportive Care: Perform gastric lavage with activated charcoal if ingestion was recent. Cool the patient with tepid sponging or ice packs to control hyperthermia.
2. Specific Antidote: Physostigmine salicylate (1 mg to 2 mg slow IV).
   • Physostigmine is a tertiary amine anticholinesterase.
   • Unlike neostigmine, it crosses the blood-brain barrier to reverse both peripheral and central toxic symptoms.
3. Symptomatic Control: Diazepam IV helps control excitement, seizures, and agitation.

High-Yield Points for GPAT & NIPER

• Chemistry: Atropine is an optically inactive racemic mixture (dl-hyoscyamine), but its pharmacological activity resides almost entirely in the l-hyoscyamine isomer.
• Absolute Contraindication: Angle-closure glaucoma and benign prostatic hyperplasia (BPH).
• Eye Recovery Time: Atropine cycloplegia lasts the longest (7–10 days). Tropicamide has the shortest duration (4–6 hours), making tropicamide preferred for routine fundoscopy.
• Drug of Choice: Atropine is the physiological antidote of choice in anticholinesterase and organophosphate insecticide poisoning.